Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 11:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2641–2664 of 21,056 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Diabetes Mellitus
Interventions: Pyridostigmine; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Hypertension, Prehypertension
Interventions: Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 65 Years
Enrollment: 271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Kidney Disease, Vitamin D Deficiency
Interventions: Ergocalciferol, Calcitriol; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Respiratory Distress Syndrome, Adult
Interventions: Albuterol Sulfate, Mini-Bronchoalveolar Lavage (BAL), Placebo; Drug · Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 13 Years and older
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 40
States / cities: Fresno, California • Sacramento, California • San Francisco, California + 19 more

Conditions: Keratoconus
Interventions: PXL Platinum 330 system; Device
Lead sponsor: Cohen Laser and Vision Center; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2034
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: Klinefelter Syndrome
Interventions: Testosterone Cypionate 200 Milligram/Milliliter Injectable Solution, Placebo injectable saline; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 31 Days to 90 Days · Male only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Arthritis, Rheumatoid
Interventions: Apremilast, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Suicide
Interventions: Supporting Wellbeing with Everyday Experiences of Peers (SWEEP); Behavioral
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 14 Years to 18 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Obesity, Childhood, Cancer, Survivorship
Interventions: NOURISH-T+, Brief NOURISH-T+; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 5 Years to 14 Years
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 10
States / cities: Washington D.C., District of Columbia • Gainesville, Florida • Miami, Florida + 6 more

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Temsirolimus, Radiation therapy; Drug · Radiation
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity
Interventions: Healthy Children, Healthy Families+ (HCHF+), Money Smart; Behavioral
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 6 Years and older
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Barrett's Esophagus
Interventions: Chromoendoscopy using Acetic Acid 2.5%, Standard random esophageal biopsies; Drug · Other
Lead sponsor: DHR Health Institute for Research and Development; Other
Eligibility: 40 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Edinburg, Texas

Conditions: Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
Interventions: Alcestobart, Tislelizumab, Bevacizumab or Bevacizumab biosimilar, Fluoropyrimidine (FP); Drug
Lead sponsor: BeiGene; Industry
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 30
States / cities: Anchorage, Alaska • Gilbert, Arizona • Cerritos, California + 23 more

Conditions: Anal Cancer, HPV-Related Carcinoma, Squamous Cell Carcinoma of the Anus
Interventions: HPV ctDNA Response based radiation, Chemotherapy, Retifanlimab; Radiation · Drug
Lead sponsor: Jennifer Dorth; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Gastroenteritis Norovirus
Interventions: Nitazoxanide, Placebo; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 12 Years to 99 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 12
States / cities: Chicago, Illinois • Kansas City, Kansas • Baltimore, Maryland + 6 more

Conditions: Radiation Therapy, Metastatic Cancer
Interventions: Questionnaires, Early Radiation Oncology Involvement Alongside Standard Oncologic Care; Other · Combination Product
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 6
States / cities: Jersey City, New Jersey • New Brunswick, New Jersey • Newark, New Jersey + 1 more

Conditions: Peripheral Nerve Blocks
Interventions: Peripheral Nerve Blocks with CAIG; Device
Lead sponsor: Clear Guide Medical; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: HIV Infections, Substance Use
Interventions: Safer Sex Skills Building (SSB); Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 380 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Richmond, Virginia

Conditions: Lung Cancer
Interventions: Carboplatin, Pemetrexed, Bevacizumab, Cixutumumab; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Atherosclerosis
Interventions: Darapladib 160 mg; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Orlando, Florida • Minneapolis, Minnesota

Conditions: Fuchs' Endothelial Dystrophy, Corneal Edema
Interventions: Endothelial keratoplasty, PRGF; Procedure · Biological
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Miami, Florida • Indianapolis, Indiana

Conditions: Breast Cancer
Interventions: cisplatin, everolimus, paclitaxel, laboratory biomarker analysis; Drug · Other
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 4
States / cities: Chattanooga, Tennessee • Jackson, Tennessee • Knoxville, Tennessee + 1 more

Conditions: Noise Correlations, Learning Quality
Interventions: Dynamic perceptual discrimination task, fMRI; Behavioral · Diagnostic Test
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Plantar Fasciitis
Interventions: Marcaine, 0.5cc AmnioFix, 1.25cc AmnioFix, Saline; Other
Lead sponsor: MiMedx Group, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Roanoke, Virginia • Salem, Virginia

Search by objective public record fields.

AchE Inhibitor and Insulin

Effect of Reducing Sedentary Behavior on Blood Pressure

hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease

Drug Study of Albuterol to Treat Acute Lung Injury

Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning

TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY

Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents

NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors

Temsirolimus and Radiation for Non-Small Cell Lung Cancer

Church, Extension and Academic Partners Empowering Healthy Families

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer

NNITS-Nitazoxanide for Norovirus in Transplant Patients Study

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

Computer Assisted Instrument Guidance (CAIG) for Orthopedic Peripheral Nerve Blocks

Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women

BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Investigating The Role of Noise Correlations in Learning

Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis